Freezing nitrogen ethanol composite as an alternative to liquid nitrogen in giant cell tumor cryotherapy: a case report and literature review
International Journal of Surgery Case Reports · 2026-04 · 138 (4) · 1184-1188
DOI: 10.1097/rc9.0000000000000020 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Surgery Case Reports, online erschienen am 24.02.2026. Verfasst von Alvian Andriyanto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic and Traumatology, Universitas Padjadjaran, Bandung, West Java, Indonesia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Giant cell tumor (GCT) of bone is a benign but locally aggressive tumor, commonly found around the knee in young adults. Despite surgical excision, GCTs are known for their high recurrence rates, prompting the use of adjuvant therapies such as cryotherapy. Liquid nitrogen is a widely used cryoablation agent but carries the risk of complications including skin necrosis, nerve injury, and pathological fractures. A newer agent, freezing nitrogen ethanol composite (FNEC), has emerged as a potentially safer alternative with similar tumoricidal effects and fewer side effects. Case Presentation: A 37-year-old man presented with a progressively enlarging, painless lump on his left knee that had been present for 5 years. Physical examination revealed a firm, non-tender mass the size of a tennis ball. Imaging studies suggested a GCT, and a preoperative biopsy confirmed a diagnosis of tenosynovial GCT. The patient underwent intralesional curettage followed by cryotherapy using FNEC as an adjuvant. To support structural integrity post-curettage, internal fixation with a plate and screw was performed.
Discussion
FNEC acts through several mechanisms including cell shrinkage, DNA fragmentation, and induction of apoptosis. Compared to liquid nitrogen, FNEC appears to provide a more controlled cryogenic effect with less risk of injury to surrounding tissues. In this case, no complications were observed during recovery.
Conclusion
FNEC may offer a safer and effective cryotherapy option for GCT management. Further clinical research is needed to confirm its long-term safety and efficacy compared to traditional methods.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic and Traumatology, Universitas Padjadjaran, Bandung, West Java, Indonesia.
Zitieren
APA
Andriyanto, A., Budi Irawan, M. N. S., & Primayudha, B. (2026). Freezing nitrogen ethanol composite as an alternative to liquid nitrogen in giant cell tumor cryotherapy: a case report and literature review. International Journal of Surgery Case Reports, 138(4), 1184-1188. https://doi.org/10.1097/rc9.0000000000000020
Vancouver
Andriyanto A, Budi Irawan MNS, Primayudha B. Freezing nitrogen ethanol composite as an alternative to liquid nitrogen in giant cell tumor cryotherapy: a case report and literature review. International Journal of Surgery Case Reports. 2026;138(4):1184-1188. doi:10.1097/rc9.0000000000000020
BibTeX
@article{Andriyanto2026,
author = {Andriyanto, Alvian and Budi Irawan, M Naseh Sajadi and Primayudha, Bangkit},
title = {Freezing nitrogen ethanol composite as an alternative to liquid nitrogen in giant cell tumor cryotherapy: a case report and literature review},
journal = {International Journal of Surgery Case Reports},
year = {2026},
volume = {138},
number = {4},
pages = {1184--1188},
doi = {10.1097/rc9.0000000000000020}
}
EUVIMED